107 related articles for article (PubMed ID: 2420904)
1. Interferon activity and its characterization in the sera of patients with premalignant lesions arising in oral mucosa.
Urata M; Yoshida H; Yanagawa T; Yura Y; Furumoto N; Azuma M; Hayashi Y; Sato M
Int J Oral Maxillofac Surg; 1986 Apr; 15(2):134-47. PubMed ID: 2420904
[TBL] [Abstract][Full Text] [Related]
2. Interferon activity and its characterization in the sera of patients with head and neck cancer.
Sato M; Yoshida H; Yanagawa T; Yura Y; Urata M; Atsumi M; Furumoto N; Hayashi Y; Takegawa Y
Cancer; 1984 Oct; 54(7):1239-51. PubMed ID: 6205740
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of human fibroblast interferon on premalignant lesions arising in oral mucosa. A pilot study.
Sato M; Yoshida H; Yanagawa T; Yura Y; Urata M; Nitta T; Azuma M; Hayashi Y
Int J Oral Surg; 1985 Apr; 14(2):184-94. PubMed ID: 2579919
[TBL] [Abstract][Full Text] [Related]
4. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
Rajendran R; Remani P; Vijayakumar T; Vasudevan DM
Ann Dent; 1990; 49(1):36-8, 51. PubMed ID: 2346298
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of premalignant lesions of the oral mucosa].
Vedtofte P; Holmstrup P
Tandlaegebladet; 1989 Sep; 93(13):493-6. PubMed ID: 2635415
[No Abstract] [Full Text] [Related]
6. [Precancerous lesions of the oral cavity. Protocol for diagnosis and therapy].
Dent Cadmos; 1990 Jan; 58(1):11, 13, 15-9 passim. PubMed ID: 2394278
[No Abstract] [Full Text] [Related]
7. Effects of intradermal administration of streptococcal preparation OK-432 on interferon and natural killer cell activities in patients with oral cancer.
Sato M; Yoshida H; Yanagawa T; Yura Y; Urata M; Atsumi M; Hayashi Y; Takegawa Y
Int J Oral Surg; 1984 Feb; 13(1):7-15. PubMed ID: 6203858
[TBL] [Abstract][Full Text] [Related]
8. Serum copper and zinc levels in premalignant and malignant lesions of the oral cavity.
Varghese I; Sugathan CK; Balasubramoniyan G; Vijayakumar T
Oncology; 1987; 44(4):224-7. PubMed ID: 3614812
[TBL] [Abstract][Full Text] [Related]
9. Examining the secretor status in the saliva of patients with oral pre-cancerous lesions.
Vidas I; Delajlija M; Temmer-Vuksan B; Stipetić-Mravak M; Cindrić N; Maricíć D
J Oral Rehabil; 1999 Feb; 26(2):177-82. PubMed ID: 10080317
[TBL] [Abstract][Full Text] [Related]
10. Management of potentially malignant oral mucosal lesions by consultant UK oral and maxillofacial surgeons.
Marley JJ; Cowan CG; Lamey PJ; Linden GJ; Johnson NW; Warnakulasuriya KA
Br J Oral Maxillofac Surg; 1996 Feb; 34(1):28-36. PubMed ID: 8645679
[TBL] [Abstract][Full Text] [Related]
11. Interferon system of human cornea cells: interferon production, characterization, and development of antiviral state.
Thacore HR; Mount DT; Chadha KC
J Interferon Res; 1982; 2(3):401-8. PubMed ID: 6182255
[TBL] [Abstract][Full Text] [Related]
12. Haematological abnormalities in oral lichen planus, candidiasis, leukoplakia and non-specific stomatitis.
Challacombe SJ
Int J Oral Maxillofac Surg; 1986 Feb; 15(1):72-80. PubMed ID: 3083007
[TBL] [Abstract][Full Text] [Related]
13. Premalignant lesions of the oral mucosa.
Jolly M
Aust Dent J; 1976 Oct; 21(5):414-22. PubMed ID: 1070974
[TBL] [Abstract][Full Text] [Related]
14. [How to improve the diagnostic and therapeutic levels of oral premalignant lesions].
Zhou ZT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):89-91. PubMed ID: 15842851
[No Abstract] [Full Text] [Related]
15. Detection of gamma interferon in the sera of patients with Behçet's disease.
Ohno S; Kato F; Matsuda H; Fujii N; Minagawa T
Infect Immun; 1982 Apr; 36(1):202-8. PubMed ID: 6176541
[TBL] [Abstract][Full Text] [Related]
16. Use of the carbon dioxide laser in the management of premalignant lesions of the oral mucosa.
Frame JW; Das Gupta AR; Dalton GA; Rhys Evans PH
J Laryngol Otol; 1984 Dec; 98(12):1251-60. PubMed ID: 6512398
[No Abstract] [Full Text] [Related]
17. [Vitamin A level in lichen ruber planus and leukoplakia of the oral cavity].
Drízhal I; Dítĕ P; Groh J
Cesk Dermatol; 1972 Apr; 47(2):74-6. PubMed ID: 5023947
[No Abstract] [Full Text] [Related]
18. Determination of role of ceruloplasmin in oral potentially malignant disorders and oral malignancy-A cross-sectional study.
Shah PH; Venkatesh R; More CB
Oral Dis; 2017 Nov; 23(8):1066-1071. PubMed ID: 28513913
[TBL] [Abstract][Full Text] [Related]
19. Screening for oral precancer with noninvasive genetic cytology.
Bremmer JF; Graveland AP; Brink A; Braakhuis BJ; Kuik DJ; Leemans CR; Bloemena E; van der Waal I; Brakenhoff RH
Cancer Prev Res (Phila); 2009 Feb; 2(2):128-33. PubMed ID: 19174582
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum beta 2-microglobulin in premalignant and malignant lesions of the oral cavity.
Anil S; Beena VT; Nair RG; Vijayakumar T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jun; 79(6):750-2. PubMed ID: 7621034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
